NumFin

West Pharmaceutical Services, Inc.

Sembol: WST

NYSE

368.35

USD

Bugünkü piyasa fiyatı

  • 47.6063

    F/K Oranı

  • 4.2581

    PEG Oranı

  • 26.83B

    MRK Kapağı

  • 0.00%

    DIV Verimi

West Pharmaceutical Services, Inc. (WST) Finansal Tablolar

Download
YıllıkÜç Aylık
DoğrusalGünlük
Grafikte için dinamiklerde varsayılan sayıları görebilirsiniz West Pharmaceutical Services, Inc. (WST). Şirketin geliri 960.931 M ortalamasını gösterir ki bu da 0.076 % gowth'dur. Tüm dönem için ortalama brüt kar 323.508 M olup 0.087 % dir. Ortalama brüt kar oranı 0.328 %dır. Şirketin geçen yılki performansı için net gelir artışı 0.013 % olup 0.215 % %'ne eşittir. tüm şirket geçmişi için ortalama.,

YıllıkÜç Aylık
10Y20Y30Y40Y

Bilanço

West Pharmaceutical Services, Inc.'nın mali yörüngesine baktığımızda, ortalama bir varlık büyümesi gözlemliyoruz. Bu oran, ilginç bir şekilde, şirketin hem en yüksek hem de en düşük seviyelerini yansıtarak olarak gerçekleşiyor. Çeyrekten çeyreğe karşılaştırıldığında, bu rakam 0 olarak ayarlanmaktadır. Geçtiğimiz yıla bakıldığında toplam varlık değişiminin 0.059 olduğu görülür. Dönen varlıklar alanında, WST raporlama para birimi cinsinden 1936.4 değerini gösterir. Bu varlıkların önemli bir kısmı, tam olarak 853.9, nakit ve kısa vadeli yatırımlarda tutulmaktadır. Bu bölüm, geçen yılın verileriyle yan yana getirildiğinde -0.045% oranında bir değişim göstermektedir. Şirketin uzun vadeli yatırımları, odak noktası olmamakla birlikte, raporlama para biriminde 210 seviyesindedir. Bu, şirketin stratejik değişimlerini yansıtan son raporlama dönemine göre 2.489%'lik bir farka işaret etmektedir. Şirketin borç profili, raporlama para biriminde 157.3 uzun vadeli toplam borcu göstermektedir. Bu rakam, yıldan yıla -0.028%'lik bir değişimi ifade etmektedir. Toplam özkaynak ile gösterilen hissedar değeri, raporlama para biriminde 2881 olarak değerlenir. Bu açıdan yıldan yıla değişim 0.073%'dir. Şirketin mali tablolarına daha derinlemesine bakıldığında ek ayrıntılar ortaya çıkmaktadır. Net alacaklar 512 değerinde, envanter 434.7 değerinde ve varsa şerefiye 108.5 değerindedir. Varsa, toplam maddi olmayan duran varlıklar 15.1 ile değerlenir.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994199319921991199019891988198719861985

balance-sheet.row.cash-and-short-term-investments

3150.6853.9894.3762.6
615.5
439.1
337.4
235.9
203
274.6
255.3
237.5
174.3
91.8
110.2
83.1
91.5
129.4
47.1
48.8
68.8
37.8
33.2
42.1
42.7
45.3
31.3
52.3
27.4
17.4
27.2
5.2
3
2.7
2.2
1.6
5.1
12.7
7.4
8.5

balance-sheet.row.short-term-investments

0000
0
0
0
0
0
0
0
7.5
12.4
0
0
0
4.3
21
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

2089.5512507.4489
385.3
319.3
288.2
253.2
200.5
181.4
179
185.7
175
147.2
126.4
138.7
128.6
136.1
110.5
107.4
75.1
114.9
66.2
61.8
60.9
74.6
64.4
60.4
69.3
67.9
57.8
43.3
41.9
42.8
41.8
44
44.1
35.4
33.4
23.3

balance-sheet.row.inventory

1745.8434.7414.8378.4
321.3
235.7
214.5
215.2
199.3
181.1
181.5
176.9
162.2
151.8
147
129.2
115.7
111.8
97.5
61.2
56.7
48
41.3
34.3
41
42.1
43.5
38.3
44
48.3
38.1
34.5
38
33.8
46.4
44.7
42.8
36.7
34.7
23.5

balance-sheet.row.other-current-assets

489.9135.8103112
51.6
64.6
54.3
39.2
39.1
36.6
35.7
34.7
38.1
73.3
42.5
38.4
25.3
29.7
21.3
17.4
17.7
9.9
15.4
17.9
28.5
22.7
20.5
19.7
16
14.8
13.6
10.2
15.8
18.1
10.8
7.1
4.5
5.1
3
1.2

balance-sheet.row.total-current-assets

7475.81936.41919.51742
1373.7
1058.7
894.4
743.5
641.9
673.7
659.3
650.7
557.3
472
436.6
397.2
366.2
412.3
281.7
237.2
226.5
216.7
161.3
158.5
173.1
184.7
159.7
170.7
156.7
148.4
136.7
93.2
98.7
97.4
101.2
97.4
96.5
89.9
78.5
56.5

balance-sheet.row.property-plant-equipment-net

5826.81512.51262.71126.8
1011.5
909.4
822
855
778.3
721
705.8
711.7
669
593.6
554.8
577.1
531
481.7
384.7
328
283.8
255.7
223.3
210.3
235.8
227.6
220.3
202.2
210.3
229.3
192.2
172.8
165.8
165.8
201.3
178.8
169
155.5
125
97.5

balance-sheet.row.goodwill

430.9108.5107.3109.9
111.1
107.8
105.8
107.7
103
104.6
108.6
114.2
112.5
111.5
112.5
114.2
105.3
109.2
102.8
89.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

61.515.118.423
30.5
29.8
20.4
21.7
23.3
37.6
42
48.3
50.6
52
55.1
55.6
50
55
66.3
159.2
43.7
48.4
44.5
32.6
52.4
66.5
61.2
51.6
58.9
63
33.9
12.7
14.1
15
17.8
14.2
12.8
12.3
9
0

balance-sheet.row.goodwill-and-intangible-assets

492.4123.6125.7132.9
141.6
137.6
126.2
129.4
126.3
142.2
150.6
162.5
163.1
163.5
167.6
169.8
155.3
164.2
169.1
159.2
43.7
48.4
44.5
32.6
52.4
66.5
61.2
51.6
58.9
63
33.9
12.7
14.1
15
17.8
14.2
12.8
12.3
9
0

balance-sheet.row.long-term-investments

810.7210204.9207.7
214.7
192.7
91.2
85.8
82.7
61.3
60.6
60.9
59.8
56.2
48.2
38.2
33.6
31.7
29.7
27.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

13125.765.648.5
16
14
24.7
25.7
66.2
70.5
66.1
61.8
90.3
85.1
64.5
69.4
63.7
61
29.8
8.3
17.9
20.5
27.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

119.421.338.455.9
36.3
29
20.5
23.4
21.3
26.4
28.5
24
24.5
28.7
22.6
19.3
18.9
34.7
23.2
63.2
86.8
82.3
80.1
109.9
96.1
73
64.4
53.4
51.5
39.4
34.6
28.7
25.8
35
23.2
22.6
20.6
22.4
24.9
25

balance-sheet.row.total-non-current-assets

7380.31893.11697.31571.8
1420.1
1282.7
1084.6
1119.3
1074.8
1021.4
1011.6
1020.9
1006.7
927.1
857.7
873.8
802.5
773.3
636.5
586.4
432.2
406.9
375.5
352.8
384.3
367.1
345.9
307.2
320.7
331.7
260.7
214.2
205.7
215.8
242.3
215.6
202.4
190.2
158.9
122.5

balance-sheet.row.other-assets

0000
0
0
-386.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

14856.13829.53616.83313.8
2793.8
2341.4
1592.4
1862.8
1716.7
1695.1
1670.9
1671.6
1564
1399.1
1294.3
1271
1168.7
1185.6
918.2
823.6
658.7
623.6
536.8
511.3
557.4
551.8
505.6
477.9
477.4
480.1
397.4
307.4
304.4
313.2
343.5
313
298.9
280.1
237.4
179

balance-sheet.row.account-payables

920.3242.4215.4232.2
213.1
156.8
130.4
138.1
122
119.8
103.1
108
102.9
89.8
63.2
68.4
67.6
80.4
61.2
46.3
29.3
29.4
19.2
22.6
27.6
25.5
20.8
18.6
23.9
22.5
19.3
14.1
20.4
16.4
18
16.3
0
0
0
0

balance-sheet.row.short-term-debt

393.2151.718.253.5
12.4
11.9
0.1
102.5
2.4
69.3
27.2
2.2
32.7
50.1
0.3
0.5
3.9
0.5
0.5
0.3
10
8
15.8
8.7
3.6
29.6
36.1
1.6
2.9
9.8
21.9
7.7
10.6
9.3
12.3
6
6.3
9.2
14.6
4.4

balance-sheet.row.tax-payables

89.53138.539.3
41.4
12.9
9.8
6
4.5
12.8
14.9
22.1
23.4
17
15
13.8
9.7
9.8
1
3.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

840.5157.3299.7271.8
313.3
317.4
196
197
226.2
228.9
309.5
371.3
378.8
299.3
358.1
379.1
382.1
394.6
235.8
280.7
150.8
167
159.2
184.3
195.8
141.5
105
87.4
95.5
104.5
35.9
24.6
31.5
49.1
66.2
52.1
48.8
51.3
29.7
26

Deferred Revenue Non Current

145.148.22.169.4
80.4
52.5
56.2
53.4
75.6
62
83.7
83.1
135.4
126
87.2
85.1
86
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

57.3---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

951.6236228.1259.7
226.9
145.4
127.7
20.5
103.4
110.8
108.9
43.3
43.5
39
42.9
41.5
34.7
61.4
1.6
78.2
0.7
81.5
52.7
18.8
48.1
48.9
47.3
37.8
38.8
29.5
45.1
25
29.9
45.2
34.4
24.7
37.2
35.5
28.3
11.9

balance-sheet.row.total-non-current-liabilities

1314.3276.7412.9384.3
435.9
426.6
298.9
303.4
358.2
356.9
461.5
528.3
573.3
501
498.9
520.8
522.5
511.8
342
361.2
241.1
247.1
247.6
259.2
272.3
215.8
170.7
141.8
159.5
164
81.9
61.6
64.8
81.2
91
77.2
84
79.6
55.6
43.2

balance-sheet.row.other-liabilities

0000
0
0
-386.5
-385.9
-370.6
-373
-377.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

405.6102.210972.3
70.5
72
0
0
0
0
0.2
0.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

3679.6948.5931.9978.4
939.3
768.2
196.1
197
228.6
298.2
336.7
765.2
835.1
744.2
668.6
691.9
681.6
694.7
498.9
486
357.6
366
335.3
334.5
351.6
319.8
274.9
199.8
225.1
225.8
168.2
108.4
125.7
152.1
155.7
124.2
127.5
124.3
98.5
59.5

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

75.218.818.818.8
18.8
18.8
18.8
18.8
18.4
18.1
17.8
17.6
8.6
8.6
8.6
8.6
8.6
8.6
8.6
8.6
8.6
4.3
4.3
4.3
4.3
4.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.retained-earnings

138183523.42987.82456.7
1846.7
1549.4
1353.4
1178.2
1071.6
964.6
902.2
805
719.9
664.5
612.6
569.4
517.3
450.3
375.7
318.6
287.5
281.2
261.2
254
269.8
278.1
249.3
252.5
217.7
210.2
189.8
169.9
153.1
139.7
160.6
162.6
148.5
134.7
126.5
113.4

balance-sheet.row.accumulated-other-comprehensive-income-loss

-742.6-143.8-183-159.6
-110.6
-149.6
-154.2
-117.3
-186.8
-162.6
-119.2
-32.4
-75.9
-71.5
-31.3
-19.7
-44.9
33.6
10.6
8.9
33.2
18.9
-13.4
-27.4
-14.5
-5.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

-1974.1-517.4-138.719.5
99.6
154.6
178.3
200.2
214.3
203.8
156.1
116.2
76.3
53.3
35.8
20.8
6.1
-7.2
19.6
-2.6
-28.2
-46.8
-50.6
-54.1
-54.8
-45.9
-19.2
25.2
34.3
43.9
37.5
18.2
15.5
13
15.5
17.1
22.9
21.1
12.4
6.1

balance-sheet.row.total-stockholders-equity

11176.528812684.92335.4
1854.5
1573.2
1396.3
1279.9
1117.5
1023.9
956.9
906.4
728.9
654.9
625.7
579.1
487.1
485.3
414.5
333.5
301.1
257.6
201.5
176.8
204.8
231.2
230.1
277.7
252
254.1
227.3
188.1
168.6
152.7
176.1
179.7
171.4
155.8
138.9
119.5

balance-sheet.row.total-liabilities-and-stockholders-equity

14856.13829.53616.83313.8
2793.8
2341.4
1592.4
1476.9
1346.1
1322.1
1293.6
1671.6
1564
1399.1
1294.3
1271
1168.7
1185.6
918.2
823.6
658.7
623.6
536.8
511.3
557.4
551.8
505.6
477.9
477.4
480.1
397.4
307.4
304.4
313.2
343.5
313
298.9
280.1
237.4
179

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
5.6
4.8
4.1
0
0
0
0
1
0.8
0.6
0.4
0.3
0.2
1.9
10.9
10.1
8.4
11.7
9.1
0
0
0
0

balance-sheet.row.total-equity

11176.528812684.92335.4
1854.5
1573.2
1396.3
1279.9
1117.5
1023.9
956.9
906.4
728.9
654.9
625.7
579.1
487.1
490.9
419.3
337.6
301.1
257.6
201.5
176.8
205.8
232
230.7
278.1
252.3
254.3
229.2
199
178.7
161.1
187.8
188.8
171.4
155.8
138.9
119.5

balance-sheet.row.total-liabilities-and-total-equity

14856.1---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

810.7210204.9207.7
214.7
192.7
91.2
85.8
82.7
61.3
60.6
68.4
72.2
56.2
48.2
38.2
37.9
21
29.7
27.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-debt

1233.7309317.9325.3
325.7
329.3
196.1
197
228.6
298.2
336.7
373.5
411.5
349.4
358.4
379.6
386
395.1
236.3
281
160.8
175
175
193
199.4
171.1
141.1
89
98.4
114.3
57.8
32.3
42.1
58.4
78.5
58.1
55.1
60.5
44.3
30.4

balance-sheet.row.net-debt

-1916.9-544.9-576.4-437.3
-289.8
-109.8
-141.3
-38.9
25.6
23.6
81.4
143.5
249.6
257.6
248.2
296.5
298.8
286.7
189.2
232.2
92
137.2
141.8
150.9
156.7
125.8
109.8
36.7
71
96.9
30.6
27.1
39.1
55.7
76.3
56.5
50
47.8
36.9
21.9

Nakit Akış Tablosu

West Pharmaceutical Services, Inc.'nın mali durumu son dönemde serbest nakit akışında kayda değer bir değişim göstererek -0.057 şeklinde bir değişim sergilemiştir. Şirket kısa süre önce 51 ihraç ederek sermayesini artırmış ve bir önceki yıla kıyasla 0.000 oranında bir farka işaret etmiştir. Şirketin yatırım faaliyetleri, raporlama para birimi cinsinden -368700000.000 tutarında net nakit kullanımıyla sonuçlanmıştır. Bu, bir önceki yıla göre 0.279 değişimidir. Aynı dönemde şirket, şirketin yatırım ve geri ödeme stratejilerini anlamada önemli olan 137.3, -6.7 ve -2.3 'i kaydetti. Şirketin finansman faaliyetleri 0.000 net nakit kullanımına yol açmış ve bir önceki yıla göre 0.000 farkı oluşmuştur. Ayrıca, şirket hissedarlarına temettü ödemeleri için -57 ayırmıştır. Aynı zamanda, -0.1 olarak adlandırılan ve bu dönemde nakit akışını önemli ölçüde etkileyen başka finansal manevralar da yapmıştır. Bu bileşenler birlikte ele alındığında, şirketin finansal durumu ve nakit akışı yönetimine yönelik stratejik yaklaşımı hakkında kapsamlı bir resim çizmektedir.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995199419931992199119901989

cash-flows.row.net-income

568.7593.4585.9661.8
346.2
241.7
206.9
150.7
143.6
95.6
127.1
112.3
80.7
75.5
65.3
72.6
86
70.7
67.1
45.6
19.4
31.9
18.4
19.6
1.6
38.7
6.7
44.4
16.4
28.7
27.3
22.5
19.7
-8.5
4.3
20.7

cash-flows.row.depreciation-and-amortization

141.3137.3120.6122.3
109.1
103.4
104.4
96.7
90.7
89.9
90
85.2
76.9
75.7
73.2
68.1
60.6
56.6
52.7
47.4
33.2
33
33
32
37
35.7
32.3
31.9
30.7
29.6
23.1
22
23.6
24.5
22.7
20.3

cash-flows.row.deferred-income-tax

-164.937.5-30.8-42.9
-5.8
15.3
0.9
41.7
21.5
-8.9
7
1.7
5.3
2.9
-1.8
-4.8
7.3
-6.4
4.9
2.3
-2.9
7.5
1.5
1.4
0.1
8.5
5.9
-7.5
-5.7
2
-2.7
2.5
0.6
-3.2
-2.6
-0.6

cash-flows.row.stock-based-compensation

19.823.323.737.5
34
24.4
15.1
16.1
19.5
29.6
18.6
21.2
15.5
8.4
7.8
7.5
6.4
11.8
0.9
0
10.9
0
0
-24.8
0
-9
0
-3.5
0.2
0.2
0.5
-1.4
0
26.1
-0.5
1.2

cash-flows.row.change-in-working-capital

-8.2-20.4-11.5-193.8
-10.3
-14.4
-28.3
-41.4
-58.7
-10.8
-30.6
-3.7
-3.3
-21.1
3
-15.6
-29.5
-14.5
-5.2
-20.4
1.9
12.7
-7.5
-15.1
4.9
-5.9
-0.3
2.8
-0.5
-15.7
-4.1
-6.3
-11.5
5.4
12.2
1.4

cash-flows.row.account-receivables

44-35.6-123.5
-46.6
-33.3
-43.8
-39.7
-23.3
-14.1
-6.3
-9.1
-25.7
-25.5
5.5
-6
1.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

-13.5-13.5-49.8-86.5
-73.7
-18.6
-7
-3.6
-21.2
-11.4
-16.2
-13.9
-8.9
-9.3
-20.7
-6.4
-13.4
-9
-22.8
0.4
-6.9
-2.8
-4.7
-0.9
-0.5
-1.2
-2.4
2.7
-2.7
-4.5
-0.7
2.7
-4.5
10.4
3.3
-2.6

cash-flows.row.account-payables

9.54.4-2.816.8
36.6
25.3
0.4
12.6
6.1
17.2
-3.5
4.6
5.8
24.6
-0.3
-0.7
-3.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

-8.2-15.376.7-0.6
73.4
12.2
22.1
-10.7
-20.3
-2.5
-4.6
14.7
25.5
-10.9
18.5
-2.5
-14.7
-5.5
17.6
-20.8
8.8
15.5
-2.8
-14.2
5.4
-4.7
2.1
0.1
2.2
-11.2
-3.4
-9
-7
-5
8.9
4

cash-flows.row.other-non-cash-items

199.35.436.1-0.9
-0.7
-3.2
-10.4
-0.5
2.8
17
-29.2
3.8
12.3
-10.7
-9.2
9.9
4.2
11
23.4
10.7
6.4
-15.9
8.5
19.6
5
1.4
26.4
-0.4
22.3
1.3
5.7
-0.8
1.6
0.1
-0.1
-0.1

cash-flows.row.net-cash-provided-by-operating-activities

756.6000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-370.5-362-284.6-253.4
-174.4
-126.4
-104.7
-130.8
-170.2
-131.6
-112.1
-155.8
-132
-96.8
-73.8
-107.8
-139.1
-129.4
-90.3
-54.1
-57.4
-60.8
-37.7
-44.1
-57.3
-63.4
-76.7
-34.4
-31.7
-31.3
-27.1
-33.5
-22.4
-25.5
-33.2
-34.3

cash-flows.row.acquisitions-net

000-2.2
0
-104
0
-6
0
0
112.1
155.8
132
96.8
-3.7
-16.9
-8.5
-4.7
0
-174.8
0
0
0
-1.1
-3.4
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

0000
0
-85.1
0
0
-8.4
0
-9.3
-14.2
-31.2
-41.2
-7.2
107.8
139.1
-22.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

0000
0
85.1
0
0
0
0
16.8
19.1
45.6
15.6
8.9
2.6
16.8
0.7
0.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-investing-activites

-6.7-6.7-3.62.5
-5.1
2.4
3.9
3.2
2.8
2.1
-111.5
-154.8
-130.4
-94.9
1.8
-107.6
-136.5
0.2
0.2
1.5
32.9
3.7
5.4
29.8
0.2
1.7
2.9
1.4
7.2
-69.3
-10.2
8
7.5
1
1.6
-5

cash-flows.row.net-cash-used-for-investing-activites

-377.2-368.7-288.2-253.1
-179.5
-228
-100.8
-133.6
-175.8
-129.5
-104
-149.9
-116
-120.5
-74
-121.9
-128.2
-155.9
-89.9
-227.4
-24.5
-57.1
-32.3
-15.4
-60.5
-61.7
-73.8
-33
-24.5
-100.6
-37.3
-25.5
-14.9
-24.5
-31.6
-39.3

cash-flows.row.debt-repayment

-2.3-2.3-44.3-2.2
-2.3
-136.4
-0.1
-34.9
-69.8
-98.8
-285.7
-341.5
-718.4
-200.4
-40.9
-10.2
-12.3
-137.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-15.2
0
-13
-1.5

cash-flows.row.common-stock-issued

52.55128.237.1
28.8
229
0
43.9
29.7
87.3
280.5
360.1
10.9
5.8
3.7
5
6.2
4.4
4.4
14.1
13.5
3
3.3
0.7
1.5
2.8
2.6
4
3.5
2.8
3.4
3.9
5.5
1.6
0.4
1.5

cash-flows.row.common-stock-repurchased

-652-451.2-222.2-151.9
-115.5
-83.1
-75.2
-78.2
-55.9
-5.6
-4.1
-5.2
-4.7
-3.5
-2.1
-1.3
-5.2
-43
0
-0.1
-0.1
0
-0.1
-0.1
-10.8
-18.1
-60.4
0
0
0
0
0
-3.3
0
-11.3
-5.3

cash-flows.row.dividends-paid

-57.6-57-54.1-51.1
-48.1
-45.1
-42.1
-39.1
-35.8
-32.4
-29.1
-26.8
-24.9
-23.2
-21.7
-20.1
-18.6
-17.5
-15.9
-14.1
-12.8
-11.8
-11.1
-10.5
-9.8
-10.3
-9.4
-9.4
-10
-8.1
-7.2
-7
-6.3
-6.2
-6.3
-5

cash-flows.row.other-financing-activites

-1.5-0.1-1.2-14.8
-89
-1.2
36.7
-0.7
17.9
8
7.6
8.3
733.7
196.6
27
4
9
278.2
-48.7
120.6
-16
-3.3
-25.1
-5.9
30.3
34.2
48.2
-1.7
-22.4
49.2
12.5
-7.6
0.5
-14.8
25.9
3.3

cash-flows.row.net-cash-used-provided-by-financing-activities

-659.6-459.6-293.6-168.1
-137.1
-36.8
-80.7
-109
-113.9
-41.5
-30.8
-5.1
-3.4
-24.7
-34
-22.6
-20.9
84.6
-60.2
120.5
-15.4
-12.1
-33
-15.8
11.2
8.6
-19
-7.1
-28.9
43.9
8.7
-10.7
-18.8
-19.4
-4.3
-7

cash-flows.row.effect-of-forex-changes-on-cash

-4.311.4-10.5-15.7
20.5
-0.7
-5.6
12.2
-1.3
-22.1
-22.8
2.6
2.1
-3.9
-3.2
2.7
-7.1
3.4
4.6
1.3
2
4.6
2.5
-2.1
-1.9
-2.3
0.8
-2.6
-0.1
0.8
0.8
-0.1
-19.1
-19.9
0.4
-0.1

cash-flows.row.net-change-in-cash

-953-40.4131.7147.1
176.4
101.7
101.5
32.9
-71.6
19.3
25.3
68.1
70.1
-18.4
27.1
-4.1
-21.2
61.3
-1.7
-20
31
4.6
-8.9
-0.6
-2.6
14
-21
25
9.9
-9.8
22
2.2
-18.8
-19.4
0.5
-3.5

cash-flows.row.cash-at-end-of-period

2482.1853.9894.3762.6
615.5
439.1
337.4
235.9
203
274.6
255.3
230
161.9
91.8
110.2
83.1
87.2
108.4
47.1
48.8
68.8
37.8
33.2
42.1
42.7
45.3
31.3
52.3
27.3
17.4
27.2
5.2
-16.1
-17.2
2.1
1.6

cash-flows.row.cash-at-beginning-of-period

3435.1894.3762.6615.5
439.1
337.4
235.9
203
274.6
255.3
230
161.9
91.8
110.2
83.1
87.2
108.4
47.1
48.8
68.8
37.8
33.2
42.1
42.7
45.3
31.3
52.3
27.3
17.4
27.2
5.2
3
2.7
2.2
1.6
5.1

cash-flows.row.operating-cash-flow

756.6776.5724584
472.5
367.2
288.6
263.3
219.4
212.4
182.9
220.5
187.4
130.7
138.3
137.7
135
129.2
143.8
85.6
68.9
69.2
53.9
32.7
48.6
69.4
71
67.7
63.4
46.1
49.8
38.5
34
44.4
36
42.9

cash-flows.row.capital-expenditure

-370.5-362-284.6-253.4
-174.4
-126.4
-104.7
-130.8
-170.2
-131.6
-112.1
-155.8
-132
-96.8
-73.8
-107.8
-139.1
-129.4
-90.3
-54.1
-57.4
-60.8
-37.7
-44.1
-57.3
-63.4
-76.7
-34.4
-31.7
-31.3
-27.1
-33.5
-22.4
-25.5
-33.2
-34.3

cash-flows.row.free-cash-flow

386.1414.5439.4330.6
298.1
240.8
183.9
132.5
49.2
80.8
70.8
64.7
55.4
33.9
64.5
29.9
-4.1
-0.2
53.5
31.5
11.5
8.4
16.2
-11.4
-8.7
6
-5.7
33.3
31.7
14.8
22.7
5
11.6
18.9
2.8
8.6

Gelir Tablosu Satırı

West Pharmaceutical Services, Inc.'nın geliri bir önceki döneme göre 0.022% oranında bir değişim gösterdi. Şirketin WST brüt kârı 1129.2 olarak raporlanmıştır. Şirketin işletme giderleri 421.8 olup, geçen yıla göre 4.873% değişim göstermiştir. Amortisman ve itfa giderleri 137.3, yani 0.138% son hesap dönemine göre değişimdir. İşletme giderleri 421.8 olarak raporlanmıştır ve yıldan yıla 4.873% değişim göstermektedir. Satış ve pazarlama giderleri 0, bir önceki yıla göre 0.000% değişimdir. Son rakamlara göre FAVÖK 0 olup, yıldan yıla -0.079% büyümeyi temsil etmektedir. Faaliyet geliri 676 olup, bir önceki yıla göre -0.079% değişim göstermektedir. Net gelirdeki değişim 0.013%'dir. Geçen yılın net geliri 593.4 idi.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994199319921991199019891988198719861985

income-statement-row.row.total-revenue

2928.62949.82886.92831.6
2146.9
1839.9
1717.4
1599.1
1509.1
1399.8
1421.4
1368.4
1266.4
1192.3
1104.7
1055.7
1051.1
1020.1
913.3
699.7
541.6
490.7
419.7
396.9
430.1
469.1
449.7
452.5
458.8
412.9
365.1
348.7
338.2
329.6
323.2
308.7
288.2
253.3
235.6
190.1

income-statement-row.row.cost-of-revenue

1840.51820.61750.71655.8
1379.1
1234.2
1172
1086.5
1008
944
973.6
933.7
878.7
853
786.6
752.1
748.5
728.3
651.5
507.1
385.7
334.9
302.1
280.8
289.7
289.1
282.2
288.5
302
265.1
225.9
222.1
217.8
221.4
221.5
206.7
197.4
174.4
160.2
128

income-statement-row.row.gross-profit

1088.11129.21136.21175.8
767.8
605.7
545.4
512.6
501.1
455.8
447.8
434.7
387.7
339.3
318.1
303.6
302.6
291.8
261.8
192.6
155.9
155.8
117.6
116.1
140.4
180
167.5
164
156.8
147.8
139.2
126.6
120.4
108.2
101.7
102
90.8
78.9
75.4
62.1

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

68.9---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

-9.9326.87.9
12
2.4
4.8
-2
-27.7
-60.1
0.2
0.5
5.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.operating-expenses

426.1421.8402.2423.5
360.9
311.6
303.2
281.7
276.6
267.1
266
272.8
251.3
221.7
213.3
197.6
191.9
168.6
160.8
121.7
106.7
94.3
81
71.9
104.7
113.6
102.8
102.1
103.5
99.5
92.1
85.5
80.7
109.5
80.5
65.9
60.4
49
44.6
38.6

income-statement-row.row.cost-and-expenses

2266.62242.42152.92079.3
1740
1545.8
1475.2
1368.2
1284.6
1211.1
1239.6
1206.5
1130
1074.7
999.9
949.7
940.4
896.9
812.3
628.8
492.4
429.2
383.1
352.7
394.4
402.7
385
390.6
405.5
364.6
318
307.6
298.5
330.9
302
272.6
257.8
223.4
204.8
166.6

income-statement-row.row.interest-income

11.8285.11
1.4
3.8
2.1
1.3
1.1
1.6
3.5
1.9
1.8
1.3
0.6
0.8
1.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

8.497.97.2
6.8
4.7
6.3
6.5
7
12.5
13
15.1
14.9
18.2
16.8
14.4
16
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-10.9-28.4-54.1-3.4
-5.6
-4.8
4.8
-2
-27.7
-60.1
0.2
0.3
-12.9
-8
-14.1
-4.5
-1.2
-25.8
-8.9
-15
0.9
11.3
-8.6
-0.9
-19.3
1.3
-29.5
1.6
-19.1
2.4
-1.2
0.5
-5.7
1.1
-4.3
4.1
2.6
-2.2
2.3
3.2

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

-9.9326.87.9
12
2.4
4.8
-2
-27.7
-60.1
0.2
0.5
5.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.total-operating-expenses

-10.9-28.4-54.1-3.4
-5.6
-4.8
4.8
-2
-27.7
-60.1
0.2
0.3
-12.9
-8
-14.1
-4.5
-1.2
-25.8
-8.9
-15
0.9
11.3
-8.6
-0.9
-19.3
1.3
-29.5
1.6
-19.1
2.4
-1.2
0.5
-5.7
1.1
-4.3
4.1
2.6
-2.2
2.3
3.2

income-statement-row.row.interest-expense

8.497.97.2
6.8
4.7
6.3
6.5
7
12.5
13
15.1
14.9
18.2
16.8
14.4
16
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.depreciation-and-amortization

141.3137.3120.6126.1
110.3
103.3
104.4
96.7
90.7
89.9
90
85.2
76.9
75.7
73.2
68.1
60.6
56.6
52.7
47.4
33.2
33
33
32
37
35.7
32.3
31.9
30.7
29.6
23.1
22
23.6
24.5
22.7
20.3
18.9
16.8
14.7
12

income-statement-row.row.ebitda-caps

811.6---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

643.5676734752.3
406.9
296.6
240.3
228.9
196.8
128.6
182
162.4
135.1
109.6
90.7
97.5
124.1
94.9
101
72.2
48.2
54.5
26.7
41.3
35.7
66.4
64.7
61.9
53.3
48.3
47.1
41.1
39.7
-1.3
21.2
36.1
30.4
29.9
30.8
23.5

income-statement-row.row.income-before-tax

667.5698679.9748.9
401.3
291.8
240.7
222.4
189.8
116.1
169
147.1
108.6
92.7
74.5
83.1
109.5
86.4
84.5
45.2
41.2
47
17.2
27.8
3.1
57.1
27.9
57.7
27.2
42.6
40.7
36.8
34
-3.8
10.7
33.9
27.5
23.2
30.2
25.4

income-statement-row.row.income-tax-expense

115.1122.3114.7107.2
72.5
59
41.4
80.9
54.4
26.3
47.2
40.2
32.7
23.5
13.6
13.5
23.7
17.2
24.6
-0.4
11.1
16.7
4.1
8.6
1.5
18.4
21.2
13.3
10.8
13.9
13.4
14.3
14.3
4.7
6.4
13.2
10.1
9.5
13.2
10.4

income-statement-row.row.net-income

568.7593.4585.9661.8
346.2
241.7
206.9
150.7
143.6
95.6
127.1
112.3
80.7
75.5
65.3
72.6
86
70.7
67.1
45.6
19.4
31.9
18.4
-5.2
1.6
38.7
6.7
44.4
16.4
28.7
27.3
23.5
19.7
-8.5
4.3
20.7
17.4
13.7
17
15
Benzer Hisse Senetleri
Bunlar da ilginizi çekebilir:
CNVVF
ConvaTec Group Plc.
3.2 USD
PNK
300753.SZ
Jiangsu Apon Medical Technology Co., Ltd..
12.59 CNY
SHZ
BLCO
Bausch + Lomb Corporation.
14.9 USD
NYSE
137310.KS
SD BioSensor, Inc.
10540 KRW
KSC
YPHDF
Ypsomed Holding AG.
362 USD
PNK
INFU
InfuSystem Holdings, Inc..
8.11 USD
AMEX
688289.SS
Sansure Biotech Inc..
20.67 CNY
SHH
7780.T
Menicon Co., Ltd..
1516.5 JPY
JPX
7741.T
HOYA Corporation.
18210 JPY
JPX
ALC.SW
Alcon Inc..
73.32 CHF
SIX
TARSONS.NS
Tarsons Products Limited.
437.6 INR
NSE

Sıkça Sorulan Sorular

Nedir West Pharmaceutical Services, Inc. (WST) toplam varlıklar?

West Pharmaceutical Services, Inc. (WST) toplam varlıklar 3829500000.000 şeklindedir.

İşletmenin yıllık geliri nedir?

Yıllık gelir 1427400000.000'dur.

Firma kâr marjı nedir?

Firma kar marjı 0.372'dir.

Şirket serbest nakit akışı nedir?

Serbest nakit akışı 5.253'dur.

İşletme net kar marjı nedir?

Net kâr marjı 0.194'dir.

Firma toplam geliri nedir?

Toplam gelir 0.220'dur.

Nedir West Pharmaceutical Services, Inc. (WST) net kar (net gelir)?

Net kar (net gelir) 593400000.000'dur.

Firmanın toplam borcu nedir?

Toplam borç 309000000.000'dir.

Faaliyet giderleri rakamı nedir?

İşletme giderleri 421800000.000'dır.

Şirket nakit rakamı nedir?

İşletme içi nakit 601800000.000'tir.